key: cord-0832128-twp0x70e authors: Alter, Benedict J; Navlani, Rohit; Abdullah, Leath; Wasan, Ajay D; Heres, Edward title: The use of telemedicine to support interventional pain care: case series and commentary date: 2021-06-04 journal: Pain Med DOI: 10.1093/pm/pnab183 sha: a807b40499ca73f00b5e6bbb5c01ae5b6f5330c7 doc_id: 832128 cord_uid: twp0x70e Incorporating indicated interventions in a multimodal approach to manage musculoskeletal pain has become standard of care. For example, in patients with radicular pain associated with intervertebral disc herniation or lumbar spinal stenosis, epidural steroid injections (ESI) are commonly used and often improve pain and function while avoiding more invasive surgical approaches. Recently, the coronavirus disease 2019 (COVID-19) pandemic has allowed remote evaluations to mitigate COVID-19 transmission using telemedicine. In this article, we review our experience in using telemedicine for interventional pain care and current literature, providing a framework for current practice and future study. During restrictive periods of COVID-19 mitigation, patients were referred for ESI, evaluated by telemedicine, and then seen in-person for a physical exam and possible ESI. After a chart review of these patients, we found that telemedicine evaluation was successfully used to support decision making about the ESI. The majority of patients referred received an ESI. During the interval between telemedicine evaluation and ESI, there was no evidence of progression of disease or neurologic deterioration. There were no emergency room visits due to pain complaints. In our literature review, similar case series supported the use of telemedicine in planning and supporting procedural care in several clinical specialties, including interventional pain management. Future research in larger cohorts will help rigorously evaluate safety and query satisfaction for both patients and providers. In conclusion, we suggest that using telemedicine to support procedural care requires more research but shows promise in increasing access to interventional pain care. The use of telemedicine has recently seen a sharp increase in frequency due to the ongoing global COVID-19 pandemic. According to the World Health Organization, telemedicine represents “healing at a distance”(1) . They define telemedicine as “the delivery of healthcare services…by health care professionals using information and communication technologies for the exchange of valid information for the diagnosis, treatment, and prevention of disease and injuries.” Telemedicine has become an important and effective option for providing patient care. However, the use of telemedicine in the context of procedural therapies for pain management is new and rapidly evolving. In this commentary, we aimed to review literature and share our experience in integrating telemedicine in procedural care. ABSTRACT: Incorporating indicated interventions in a multimodal approach to manage 36 musculoskeletal pain has become standard of care. For example, in patients with radicular pain 37 associated with intervertebral disc herniation or lumbar spinal stenosis, epidural steroid 38 injections (ESI) are commonly used and often improve pain and function while avoiding more 39 invasive surgical approaches. Recently, the coronavirus disease 2019 (COVID-19) pandemic has 40 allowed remote evaluations to mitigate COVID-19 transmission using telemedicine. In this 41 article, we review our experience in using telemedicine for interventional pain care and current 42 literature, providing a framework for current practice and future study. During restrictive periods 43 of COVID-19 mitigation, patients were referred for ESI, evaluated by telemedicine, and then 44 seen in-person for a physical exam and possible ESI. After a chart review of these patients, we 45 found that telemedicine evaluation was successfully used to support decision making about the 46 ESI. The majority of patients referred received an ESI. During the interval between telemedicine 47 evaluation and ESI, there was no evidence of progression of disease or neurologic deterioration. 48 There were no emergency room visits due to pain complaints. In our literature review, similar 49 case series supported the use of telemedicine in planning and supporting procedural care in 50 several clinical specialties, including interventional pain management. Future research in larger 51 cohorts will help rigorously evaluate safety and query satisfaction for both patients and 52 providers. In conclusion, we suggest that using telemedicine to support procedural care requires 53 more research but shows promise in increasing access to interventional pain care. Academy of Pain Medicine Pain Medicine 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 The use of telemedicine has recently seen a sharp increase in frequency due to the 58 ongoing global COVID-19 pandemic. According to the World Health Organization, telemedicine 59 represents "healing at a distance" 1 . They define telemedicine as "the delivery of healthcare 60 services...by health care professionals using information and communication technologies for the 61 exchange of valid information for the diagnosis, treatment, and prevention of disease and 62 injuries." Telemedicine has become an important and effective option for providing patient care. However, the use of telemedicine in the context of procedural therapies for pain management is 64 new and rapidly evolving. In this commentary, we aimed to review literature and share our 65 experience in integrating telemedicine in procedural care. Within the field of pain medicine, telemedicine has been used for chronic pain treatments 76 using mobile applications and wearable technology to track symptomatology, adherence to 77 physical activity recommendations, and follow patient progress longitudinally 5 . Telemedicine 78 has also been used to deliver psychotherapies in efforts to alleviate chronic pain 6 . Generally, 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 in-person visits should be minimized and that semi-urgent procedures could be triaged using 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 125 this was relaxed over time as safety protocols were implemented and Pennsylvania relaxed 126 mitigation measures. Inclusion into the case review required patients be referred specifically for 127 ESI and seen initially by telemedicine. Exclusion criteria were referrals for general evaluation, 128 not specifically for ESI. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 29 patients who were recommended additional treatments, 51.5% were in compliance at the time 149 of their in-person procedure visit. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 referral and initial telemedicine evaluation in the pain clinic ranged from 1-131 days with a mean 172 of 37.6 days (median of 25 days; standard deviation 36.3 days). We found that this time interval 173 was initially long, but decreased with the phased relaxation of COVID mitigation (Fig 1) , 174 suggesting that our approach could efficiently be incorporated into clinical practice after the 175 COVID pandemic resolves without delays in patient care. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 least stringent COVID-mitigation phase (green), logrank test for trend: Chi2(df 1) = 5.237, p = 235 0.0221. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 Development and Patient Satisfaction of a New Telemedicine Service for Pain Management at 213 Massachusetts General Hospital to the Island of Martha's Vineyard Caring for patients with pain during the 216 COVID-19 pandemic: consensus recommendations from an international expert panel Multispecialty Organizations During the COVID-19 Pandemic and Public Health Crises Wasan 222 A. Telemedicine for Chronic Pain in the COVID-19 Era and Beyond